Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy.
Peña-Sagredo JL, Fariñas MC, Perez-Zafrilla B, Cruz-Valenciano A, Crespo M, Joven-Ibañez B, Riera E, Manero-Ruiz FJ, Chalmeta I, Hernández MV, Rodríguez-Gómez M, Maíz O, López R, Cobo T, Pita J, Carmona L, Gonzalez-Gay MA; BIOBADASER and EMECAR Groups. Peña-Sagredo JL, et al. Clin Exp Rheumatol. 2009 Nov-Dec;27(6):920-5. Clin Exp Rheumatol. 2009. PMID: 20149306
Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis.
González-Álvaro I, Ortiz AM, Alvaro-Gracia JM, Castañeda S, Díaz-Sánchez B, Carvajal I, García-Vadillo JA, Humbría A, López-Bote JP, Patiño E, Tomero EG, Vicente EF, Sabando P, García-Vicuña R. González-Álvaro I, et al. Among authors: tomero eg. PLoS One. 2011;6(12):e29492. doi: 10.1371/journal.pone.0029492. Epub 2011 Dec 29. PLoS One. 2011. PMID: 22242124 Free PMC article.
Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study.
Fernández-Nebro A, de la Fuente JL, Carreño L, Izquierdo MG, Tomero E, Rúa-Figueroa I, Hernández-Cruz BE, Narváez J, Ucar E, Olivé A, Zea A, Fernández-Castro M, Raya-Álvarez E, Pego-Reigosa JM, Freire M, Martínez-Taboada VM, Pérez-Venegas J, Sánchez-Atrio AI, Villa-Blanco I, Manrique-Arija S, López-Longo FJ, Carreira PE, Martínez-Pérez R, García-Vicuña R. Fernández-Nebro A, et al. Lupus. 2012 Sep;21(10):1063-76. doi: 10.1177/0961203312446627. Epub 2012 Jul 11. Lupus. 2012. PMID: 22786985 Clinical Trial.
Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
Fernández-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, Collantes-Estévez E, Mulero J, Muñoz-Fernández S, Zarco P, Carmona L; ESPERANZA Study Group. Fernández-Espartero C, et al. Ann Rheum Dis. 2014 Jul;73(7):1350-5. doi: 10.1136/annrheumdis-2012-202976. Epub 2013 May 24. Ann Rheum Dis. 2014. PMID: 23709245
The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB).
Fernández-Nebro A, Marenco JL, López-Longo F, Galindo M, Hernández-Cruz BE, Narváez J, Rúa-Figueroa I, Raya-Alvarez E, Zea A, Freire M, Sánchez-Atrio AI, García-Vicuña R, Pego-Reigosa JM, Manrique-Arija S, Nieves-Martín L, Carreño L; LESIMAB GROUP. Fernández-Nebro A, et al. Lupus. 2014 Sep;23(10):1014-22. doi: 10.1177/0961203314534909. Epub 2014 May 15. Lupus. 2014. PMID: 24833667
Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study.
Ortea I, Roschitzki B, López-Rodríguez R, Tomero EG, Ovalles JG, López-Longo J, de la Torre I, González-Alvaro I, Gómez-Reino JJ, González A. Ortea I, et al. Among authors: tomero eg. PLoS One. 2016 Apr 6;11(4):e0153140. doi: 10.1371/journal.pone.0153140. eCollection 2016. PLoS One. 2016. PMID: 27050469 Free PMC article.
50 results